International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema
Clinical trial NCT01217671 · COMPLETED
Trial details
- NCT number
- NCT01217671
- Sponsor
- Kamada, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2014-11-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.